The pharmaceutical industry continues to be a hotbed of patent innovation. Activity is driven by the evolution of new treatment paradigms, and gravity of unmet need, as well as the growing importance of technologies such as pharmacogenomics, digital therapeutics, and artificial intelligence. In the last three years alone, there have been over 787,000 patents filed and granted in the pharmaceutical industry, according to GlobalData’s report on Innovation in pharma: alopecia treatment drugsBuy the report here.

Smarter leaders trust GlobalData

However, not all innovations are equal and nor do they follow a constant upward trend. Instead, their evolution takes the form of an S-shaped curve that reflects their typical lifecycle from early emergence to accelerating adoption, before finally stabilizing and reaching maturity.

Identifying where a particular innovation is on this journey, especially those that are in the emerging and accelerating stages, is essential for understanding their current level of adoption and the likely future trajectory and impact they will have.

80+ innovations will shape the pharmaceutical industry

According to GlobalData’s Technology Foresights, which plots the S-curve for the pharmaceutical industry using innovation intensity models built on over 668,000 patents, there are 80+ innovation areas that will shape the future of the industry.

Within the emerging innovation stage, engineered multispecific antibodies, tyrosine kinase inhibitors, and mutant DNA polymerases are disruptive technologies that are in the early stages of application and should be tracked closely. Phenotypic drug screening, antibody-drug conjugates, and polysaccharide-protein conjugate vaccines are some of the accelerating innovation areas, where adoption has been steadily increasing. Among maturing innovation areas are drug delivery nanoparticles and antibody encoding polynucleotide libraries, which are now well established in the industry.

Innovation S-curve for the pharmaceutical industry

Alopecia treatment drugs is a key innovation area in pharmaceutical

Alopecia treatment drugs are used to treat alopecia areata, an autoimmune condition in which hair is lost in patches in size of a large coin. The hair loss can occur in any hair-containing part of skin.

GlobalData’s analysis also uncovers the companies at the forefront of each innovation area and assesses the potential reach and impact of their patenting activity across different applications and geographies. According to GlobalData, there are 440+ companies, spanning technology vendors, established pharmaceutical companies, and up-and-coming start-ups engaged in the development and application of alopecia treatment drugs.

Key players in alopecia treatment drugs – a disruptive innovation in the pharmaceutical industry

‘Application diversity’ measures the number of applications identified for each patent. It broadly splits companies into either ‘niche’ or ‘diversified’ innovators.

‘Geographic reach’ refers to the number of countries each patent is registered in. It reflects the breadth of geographic application intended, ranging from ‘global’ to ‘local’.

Patent volumes related to alopecia treatment drugs

Company Total patents (2010 - 2022) Premium intelligence on the world's largest companies
Johnson & Johnson 293 Unlock Company Profile
AbbVie 267 Unlock Company Profile
Giuliani 198 Unlock Company Profile
Amorepacific Group 196 Unlock Company Profile
Caregen 153 Unlock Company Profile
Taisho Pharmaceutical 95 Unlock Company Profile
Galderma Research and Development 93 Unlock Company Profile
Berkshire Hathaway 68 Unlock Company Profile
Igisu 52 Unlock Company Profile
HDT Global 51 Unlock Company Profile
Pierre Fabre Foundation 47 Unlock Company Profile
Equillium 47 Unlock Company Profile
LG 45 Unlock Company Profile
Dr. Wolff Gruppe 42 Unlock Company Profile
Kao 42 Unlock Company Profile
Almirall 39 Unlock Company Profile
Joventis 39 Unlock Company Profile
Puretech Health 35 Unlock Company Profile
Rohto Pharmaceutical 34 Unlock Company Profile
Kobayashi Pharmaceutical 33 Unlock Company Profile
Royal DSM 33 Unlock Company Profile
Symrise 33 Unlock Company Profile
Lonza Group 32 Unlock Company Profile
Aneira Pharma 31 Unlock Company Profile
MediPal 30 Unlock Company Profile
Biolab Sanus Farmaceutica 30 Unlock Company Profile
Shiseido 29 Unlock Company Profile
Lipidor 28 Unlock Company Profile
Nogra Two 28 Unlock Company Profile
Triple Hair 27 Unlock Company Profile
Direct Biologics 27 Unlock Company Profile
Anagenics 27 Unlock Company Profile
Histide 25 Unlock Company Profile
Samson Clinical 25 Unlock Company Profile
Legacy Healthcare 24 Unlock Company Profile
Biomendics 24 Unlock Company Profile
Phyto Tech 23 Unlock Company Profile
Cosmax 23 Unlock Company Profile
CIMTECH 22 Unlock Company Profile
Huons Global 22 Unlock Company Profile
Mallinckrodt 22 Unlock Company Profile
Jina Pharmaceuticals 20 Unlock Company Profile
Prostemics 20 Unlock Company Profile
Montefiore Medical Center 20 Unlock Company Profile
MediPost 19 Unlock Company Profile
Nestle 18 Unlock Company Profile
International Flavors & Fragrances 18 Unlock Company Profile
Yuhan 18 Unlock Company Profile
TCI 18 Unlock Company Profile
Kirin 17 Unlock Company Profile

Source: GlobalData Patent Analytics

Johnson & Johnson, AbbVie, and Giuliani are among the leading patent filers for alopecia treatment drugs. AbbVie Ventures invested $15m in the alopecia programme of Stemson Therapeutics, which is working on new approach for the treatment of alopecia using induced pluripotent stem cells (iPSCs)-derived folliculogenic cells. Another leading patent filer Caregen, is developing synthetic peptide for the treatment of alopecia. Stemson Therapeutics.

In terms of application diversity, Biolab Sanus Farmaceutica is the top company, followed by Puretech Health and Samson Clinical. By geographic reach, Equillium holds the top position, while Almirall and Joventis are in second and third positions, respectively.

To further understand the key themes and technologies disrupting the pharmaceutical industry, access GlobalData’s latest thematic research report on Pharmaceutical.

Premium Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData’s Patent Analytics tracks patent filings and grants from official offices around the world. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.